Angel Cequier

Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial

de Winter RJ, Zaman A, Hara H, Gao C, Ono M, Garg S, Smits P, Tonino P, Hofma S, Moreno R, Choudhury A, Petrov I, Cequier A, Colombo A, Kaul U, Onuma Y, Serruys P

August 19, 2022 | 10.4244/EIJ-D-21-00766

Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial

Ortega-Paz L, Brugaletta S, Gomez-Lara J, Alfonso F, Cequier A, Romaní S, Bordes P, Serra A, Iñiguez A, Salinas P, García del Blanco B, Goicolea J, Hernández-Antolín R, Cuesta J, Gómez-Hospital JA, Sabaté M

August 5, 2022 | 10.4244/EIJ-D-21-00651

Thin- versus thick-strut polymer-free biolimus-eluting stents: the BioFreedom QCA randomised trial

Sabaté M, Jensen L, Tilsted H, Moreno R, García del Blanco B, Macaya C, Perez de Prado A, Cequier A, Pérez-Fuentes P, Schütte D, Costa R, Stoll H, Lassen J

June 25, 2021 | 10.4244/EIJ-D-20-01162

In-hospital outcomes of COVID-19 ST-elevation myocardial infarction patients

Rodríguez-Leor O, Cid Alvarez A, Perez de Prado A, Rossello X, Ojeda S, Serrador A, López-Palop R, Martin-Moreiras J, Rumoroso J, Cequier A, Ibáñez B, Cruz-González I, Romaguera R, Moreno R

April 20, 2021 | 10.4244/EIJ-D-20-00935

Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: vascular healing outcomes from the MAGSTEMI trial

Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romaní S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernández-Antolín R, Antuña P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gómez-Hospital JA, Sabaté M

December 4, 2020 | 10.4244/EIJ-D-20-00198

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Onuma Y, Chevalier B, Ono M, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza R, West N, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Serruys P

December 4, 2020 | 10.4244/EIJ-D-20-00024

Coronary vasomotor function and myocardial flow with bioresorbable vascular scaffolds or everolimus-eluting metallic stents: a randomised trial

Gomez-Lara J, Salvatella N, Romaguera R, Brugaletta S, Nato M, Roura G, Ferreiro J, Teruel L, Gracida M, Sabaté M, Vaquerizo B, Cequier A, Gomez-Hospital J

June 12, 2020 | 10.4244/EIJ-D-18-01203

Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study

Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Munzel T, Cequier A, Buono A, Serruys P, Sabaté M

March 20, 2020 | 10.4244/EIJ-D-19-00773

Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)

Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys P, Räber L, Sabaté M, Serruys P

December 7, 2018 | 10.4244/EIJ-D-18-00839

Association between coronary atherosclerosis progression and in-stent neoatherosclerosis in patients with ST-elevation myocardial infarction at five-year follow-up

Paoletti G, Gomez-Lara J, Brugaletta S, Nato M, Romaguera R, Roura G, Ferreiro JL, Teruel L, Gracida M, Ortega-Paz L, Gomez-Hospital J, Sabaté M, Cequier A

June 20, 2018 | 10.4244/EIJ-D-17-00255

Invasive strategy and frailty in very elderly patients with acute coronary syndromes

Llao I, Ariza-Sole A, Sanchis J, Alegre O, López-Palop R, Formiga F, Marin F, Vidan MT, Martínez-Sellés M, Sionis A, Vives-Borras M, Gomez-Hospital J, Gomez-Lara J, Roura G, Díez-Villanueva P, Núñez-Gil I, Maristany J, Asmarats L, Bueno H, Abu-Assi E, Cequier A

June 14, 2018 | 10.4244/EIJ-D-18-00099

Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial

Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabaté M

March 20, 2018 | 10.4244/EIJ-D-17-00608

Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)

Chevalier B, Cequier A, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Onuma Y, Serruys P

January 19, 2018 | 10.4244/EIJ-D-17-00873

Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial

Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabaté M

August 4, 2017 | 10.4244/EIJ-D-16-00512

Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial

Fabris E, van't Hof A, Hamm C, Lapostolle F, Lassen J, Goodman S, ten Berg J, Bolognese L, Cequier A, Chettibi M, Hammett C, Huber K, Janzon M, Merkely B, Storey R, Zeymer U, Cantor W, Rousseau H, Vicaut E, Montalescot G

May 15, 2017 | 10.4244/EIJ-D-16-00965

IVUS-guided treatment strategies for definite late and very late stent thrombosis

Gomez-Lara J, Salvatella N, Gonzalo N, Hernandez Hernandez F, Fernández-Nofrerias E, Sanchez Recalde A, Bastante T, Marcano A, Romaguera R, Ferreiro JL, Roura G, Teruel L, Ariza-Sole A, Miranda-Guardiola F, Garcia-Abad V, Gomez-Hospital J, Alfonso F, Cequier A

December 9, 2016 | 10.4244/EIJY15M12_08

Preserved endothelial vasomotor function after everolimus-eluting stent implantation

Roura G, Homs S, Ferreiro JL, Gomez-Lara J, Romaguera R, Teruel L, Sanchez-Elvira G, Ariza-Sole A, Gomez-Hospital J, Cequier A

October 20, 2015 | 10.4244/EIJY14M07_09

Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials

Taniwaki M, Stefanini G, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabaté M, Windecker S

August 20, 2015 | 10.4244/EIJY14M07_12

Rationale and design of the RIBS IV randomised clinical trial (drug-eluting balloons versus everolimus-eluting stents for patients with drug-eluting stent restenosis)

Alfonso F, Pérez-Vizcayno M, Cardenas A, García del Blanco B, García Touchard A, Lopez-Minguez J, Rivero F, Masotti M, Zueco J, Cequier A, Morís C, Fernandez Ortiz A, Escaned J, Jiménez-Quevedo P, Gonzalo N, Fernandez C, Macaya C

July 20, 2015 | 10.4244/EIJY14M09_07

Coronary perforation after bioresorbable vascular scaffold implantation

Gomez-Lara J, Teruel L, Romaguera R, Roura G, Ferreiro JL, Sanchez-Elvira G, Gomez-Hospital J, Cequier A

April 20, 2015 | 10.4244/EIJV10I12A253

Angel Cequier

Latest news